title: The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.
abstract: The death of dopaminergic neurons induced by systemic administration of mitochondrial respiratory chain complex I inhibitors such as 1-methyl-4-phenylpyridinium (MPP(+); given as the prodrug 1-methyl-1,2,3,6-tetrahydropyridine) or the pesticide rotenone have raised the question as to whether this family of compounds are the cause of some forms of Parkinsonism. We have examined the neurotoxic potential of another complex I inhibitor, annonacin, the major acetogenin of Annona muricata (soursop), a tropical plant suspected to be the cause of an atypical form of Parkinson disease in the French West Indies (Guadeloupe). When added to mesencephalic cultures for 24 h, annonacin was much more potent than MPP(+) (effective concentration [EC(50)]=0.018 versus 1.9 microM) and as effective as rotenone (EC(50)=0.034 microM) in killing dopaminergic neurons. The uptake of [(3)H]-dopamine used as an index of dopaminergic cell function was similarly reduced. Toxic effects were seen at lower concentrations when the incubation time was extended by several days whereas withdrawal of the toxin after a short-term exposure (<6 h) arrested cell demise. Unlike MPP(+) but similar to rotenone, the acetogenin also reduced the survival of non-dopaminergic neurons. Neuronal cell death was not excitotoxic and occurred independently of free radical production. Raising the concentrations of either glucose or mannose in the presence of annonacin restored to a large extent intracellular ATP synthesis and prevented neuronal cell demise. Deoxyglucose reversed the effects of both glucose and mannose. Other hexoses such as galactose and fructose were not protective. Attempts to restore oxidative phosphorylation with lactate or pyruvate failed to provide protection to dopaminergic neurons whereas idoacetate, an inhibitor of glycolysis, inhibited the survival promoting effects of glucose and mannose indicating that these two hexoses acted independently of mitochondria by stimulating glycolysis. In conclusion, our study demonstrates that annonacin promotes dopaminergic neuronal death by impairment of energy production. It also underlines the need to address its possible role in the etiology of some atypical forms of Parkinsonism in Guadeloupe.
authors.affiliation: Department of Neurology, CHU Antilles-Guyane, BP.465, 97159 Pointe-à-Pitre, Guadeloupe, France. annie.lannuzel@chu-guadeloupe.fr
authors.forename: A
authors.initials: A
authors.lastname: Lannuzel
authors.forename: P P
authors.initials: PP
authors.lastname: Michel
authors.forename: G U
authors.initials: GU
authors.lastname: Höglinger
authors.forename: P
authors.initials: P
authors.lastname: Champy
authors.forename: A
authors.initials: A
authors.lastname: Jousset
authors.forename: F
authors.initials: F
authors.lastname: Medja
authors.forename: A
authors.initials: A
authors.lastname: Lombès
authors.forename: F
authors.initials: F
authors.lastname: Darios
authors.forename: C
authors.initials: C
authors.lastname: Gleye
authors.forename: A
authors.initials: A
authors.lastname: Laurens
authors.forename: R
authors.initials: R
authors.lastname: Hocquemiller
authors.forename: E C
authors.initials: EC
authors.lastname: Hirsch
authors.forename: M
authors.initials: M
authors.lastname: Ruberg
mesh_terms: D015655:1-Methyl-4-phenylpyridinium / Q000633:toxicity; D000111:Acetylcysteine / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000032:analysis; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001569:Benzodiazepines / Q000494:pharmacology; D002470:Cell Survival; D002478:Cells, Cultured; D002839:Chromans / Q000494:pharmacology; D003847:Deoxyglucose / Q000378:metabolism; D016291:Dizocilpine Maleate / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004622:Embryo, Mammalian; D004734:Energy Metabolism / Q000187:drug effects* / Q000502:physiology; D018691:Excitatory Amino Acid Antagonists; D005260:Female; D005663:Furans / Q000737:chemistry / Q000633:toxicity*; D005947:Glucose / Q000494:pharmacology; D006540:Herbicides / Q000633:toxicity; D006601:Hexoses / Q000494:pharmacology; D007306:Insecticides / Q000633:toxicity; D042541:Intracellular Space / Q000378:metabolism; D007783:Lactones / Q000737:chemistry / Q000633:toxicity*; D008297:Male; D008358:Mannose / Q000494:pharmacology; D008636:Mesencephalon / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D008869:Microtubule-Associated Proteins / Q000378:metabolism; D008928:Mitochondria / Q000187:drug effects*; D009474:Neurons / Q000187:drug effects* / Q000502:physiology; D009498:Neurotoxins / Q000737:chemistry / Q000633:toxicity*; D010936:Plant Extracts / Q000737:chemistry / Q000633:toxicity; D011247:Pregnancy; D051381:Rats; D017208:Rats, Wistar; D017382:Reactive Oxygen Species; D012402:Rotenone / Q000633:toxicity; D014316:Tritium / Q000378:metabolism; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
chemical_list: D000975:Antioxidants; D002839:Chromans; D018691:Excitatory Amino Acid Antagonists; D005663:Furans; D006540:Herbicides; D006601:Hexoses; D007306:Insecticides; D007783:Lactones; D008869:Microtubule-Associated Proteins; D009498:Neurotoxins; D010936:Plant Extracts; D017382:Reactive Oxygen Species; D012402:Rotenone; D014316:Tritium; C061950:GYKI 52466; D001569:Benzodiazepines; C053442:annonacin; D016291:Dizocilpine Maleate; D000255:Adenosine Triphosphate; D003847:Deoxyglucose; D014446:Tyrosine 3-Monooxygenase; D005947:Glucose; D008358:Mannose; D015655:1-Methyl-4-phenylpyridinium; C010643:6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid; D004298:Dopamine; D000111:Acetylcysteine